Recreate medicines (Nasdak:LGNDAt $ 400 million at 0.75 % of the 2030 convertible notes in a special position for qualified institutional buyers.
Buyers have a 13 -day option to buy up to $ 60 million. The sale is expected to be closed in August
https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png
Source link